Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-16 4:22 pm Purchase |
2025-04-14 | 13G | Athira Pharma, Inc. ATHA |
Steven Michael Oliveira | 1,994,649 5.109% |
1,994,649 (New Position) |
Filing History |
| 2025-02-14 10:21 am Purchase |
2024-12-31 | 13G | Athira Pharma, Inc. ATHA |
BML Investment Partners, L.P. | 3,027,163 7.800% |
542,718 (+21.84%) |
Filing History |
| 2025-02-14 09:59 am Unchanged |
2024-12-31 | 13G | Athira Pharma, Inc. ATHA |
BML Investment Partners, L.P. | 2,484,445 6.500% |
0 (Unchanged) |
Filing History |
| 2024-11-14 4:17 pm Sale |
2024-09-30 | 13G | Athira Pharma, Inc. ATHA |
Baker Bros. Advisors LP | 0 0.000% |
-3,153,807 (Position Closed) |
Filing History |
| 2024-11-07 1:15 pm Purchase |
2024-11-01 | 13G | Athira Pharma, Inc. ATHA |
BML Investment Partners, L.P. | 2,484,445 6.500% |
2,484,445 (New Position) |
Filing History |
| 2024-10-31 4:16 pm Purchase |
2024-10-30 | 13D | Athira Pharma, Inc. ATHA |
PERCEPTIVE ADVISORS LLC | 5,479,348 14.200% |
20,900 (+0.38%) |
Filing History |
| 2024-02-14 4:21 pm Purchase |
2023-12-31 | 13G | Athira Pharma, Inc. ATHA |
Baker Bros. Advisors LP | 3,153,807 8.300% |
3,153,807 (New Position) |
Filing History |
| 2023-12-29 5:15 pm Purchase |
2023-12-27 | 13D | Athira Pharma, Inc. ATHA |
PERCEPTIVE ADVISORS LLC | 5,458,448 14.300% |
647,299 (+13.45%) |
Filing History |
| 2023-07-07 4:35 pm Sale |
2023-06-30 | 13G | Athira Pharma, Inc. ATHA |
BLACKROCK INC BLK |
669,768 1.800% |
-1,693,453 (-71.66%) |
Filing History |
| 2023-04-20 5:27 pm Purchase |
2023-04-10 | 13G | Athira Pharma, Inc. ATHA |
KAYNE RICHARD A | 1,983,668 5.300% |
1,983,668 (New Position) |
Filing History |
| 2023-02-14 10:27 am Sale |
2022-12-31 | 13G | Athira Pharma, Inc. ATHA |
RTW Investments, LP | 0 0.000% |
-1,906,557 (Position Closed) |
Filing History |
| 2023-02-01 4:54 pm Sale |
2022-12-31 | 13G | Athira Pharma, Inc. ATHA |
BLACKROCK INC BLK |
2,363,221 6.200% |
-92,463 (-3.77%) |
Filing History |
| 2023-01-30 1:38 pm Sale |
2022-12-31 | 13G | Athira Pharma, Inc. ATHA |
FRANKLIN RESOURCES INC BEN |
0 0.000% |
-2,080,050 (Position Closed) |
Filing History |
| 2022-07-01 4:45 pm Purchase |
2022-06-30 | 13D | Athira Pharma, Inc. ATHA |
PERCEPTIVE ADVISORS LLC | 4,811,149 12.800% |
1,385,233 (+40.43%) |
Filing History |
| 2022-02-14 5:02 pm Sale |
2021-12-31 | 13G | Athira Pharma, Inc. ATHA |
VIKING GLOBAL INVESTORS LP | 0 0.000% |
-2,120,653 (Position Closed) |
Filing History |
| 2022-02-14 4:14 pm Sale |
2021-12-31 | 13G | Athira Pharma, Inc. ATHA |
Venrock Healthcare Capital Partners II, L.P. | 1,000,000 2.700% |
-691,623 (-40.89%) |
Filing History |
| 2022-02-14 08:09 am Sale |
2021-12-31 | 13G | Athira Pharma, Inc. ATHA |
RTW Investments, LP | 1,906,557 5.100% |
-779,222 (-29.01%) |
Filing History |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Athira Pharma, Inc. ATHA |
BLACKROCK INC BLK |
2,455,684 6.600% |
2,455,684 (New Position) |
Filing History |
| 2022-02-03 11:55 am Purchase |
2021-12-31 | 13G | Athira Pharma, Inc. ATHA |
FRANKLIN RESOURCES INC BEN |
2,080,050 5.600% |
2,080,050 (New Position) |
Filing History |
| 2021-02-16 4:06 pm Purchase |
2020-12-31 | 13G | Athira Pharma, Inc. ATHA |
Venrock Healthcare Capital Partners II, L.P. | 1,691,623 5.200% |
34,000 (+2.05%) |
Filing History |